(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs ...

Novartis is serving up $60 million to partner with Matchpoint Therapeutics in hopes of getting an oral covalent inhibitor ...

Matchpoint Therapeutics partners with Novartis to develop oral covalent inhibitors for inflammatory diseases, with potential ...

A roundup of global health news reveals rising challenges, including Brazil's bird flu outbreak, vaccine policy changes by ...

Avalere Health, a 2025 MM+M Agency 100 honoree, named Rhiannon Meaden, PhD, as head of medical strategy and transformation.

Indiana has a new name. With its growing field of precision medicine and life sciences, the state has secured the title of Radiopharmaceutical Capital of the World.

However, while excitement builds about the line-up, dancer Amy, 34, told in an exclusive interview with the MailOnline how ...

Strictly Come Dancing professional Amy Dowden had to withdraw from the show last year after suffering a foot injury, but says ...

Musawat Shams Zahedi has been appointed as the new managing director of Novartis Bangladesh. The decision was taken at a meeting of the company's board of directors on July 14, according to a press ...

Novartis introduces the first approved malaria treatment for newborns and young infants Safer dosing helps lower the risk of ...

Strictly Come Dancing star Amy Dowden said she was “deluded” and hit an “all-time low” after finishing cancer treatment - but ...

MIT professor, Dr. Leonard Guarente, conducts research into sirtuin genes and the power of a molecule called NAD ...